₹828.20
₹-17.75 (-2.10%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹20,951 Cr
P/E
31.63
ROE
11.70%
ROCE
13.63%
About Granules India Ltd
Granules India is primarily involved in the manufacturing and selling of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation intermediates (PFIs) and Finished Dosages (FDs).(Source : 202503-Annual Report Page No:134)
Founded
1991
CEO
C Krishna Prasad
Employees
6,523
HQ
Hyderabad, India
About Granules India Ltd
Granules India is primarily involved in the manufacturing and selling of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation intermediates (PFIs) and Finished Dosages (FDs).(Source : 202503-Annual Report Page No:134)
Founded:1991
CEO:C Krishna Prasad
Employees:6,523
HQ:Hyderabad, India
Finished Products
1Sale of Products
₹10,099.56Cr2Other Operating Revenue
₹159.66CrRaw Materials
1Raw Material Consumed
₹4,806.29CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹910
52W Low
₹456
Volume610.12K
Avg VolumeN/A
Beta0.84
Dividend Yield0.21%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
31.63x
Valuation
P/B Ratio
4.44x
Valuation
EPS
₹26.73
Valuation
Dividend Yield
0.21%
Valuation
ROE
11.70%
Profitability
ROCE
13.63%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceutical products including iRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
4.1%
International
95.9%
Outside India95.9%
Within India4.1%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.30x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
6.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.